Abbott

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Abbott 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ABT

Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. 

CEO
Robert B. Ford
CEORobert B. Ford
Employees
114,000
Employees114,000
Headquarters
Abbott Park, Illinois
HeadquartersAbbott Park, Illinois
Founded
1888
Founded1888
Employees
114,000
Employees114,000

ABT Key Statistics

Market cap
216.56B
Market cap216.56B
Price-Earnings ratio
15.78
Price-Earnings ratio15.78
Dividend yield
1.88%
Dividend yield1.88%
Average volume
5.75M
Average volume5.75M
High today
$126.71
High today$126.71
Low today
$123.92
Low today$123.92
Open price
$125.80
Open price$125.80
Volume
4.56M
Volume4.56M
52 Week high
$141.23
52 Week high$141.23
52 Week low
$110.86
52 Week low$110.86

Stock Snapshot

With a market cap of 216.56B, Abbott(ABT) trades at $124.54. The stock has a price-to-earnings ratio of 15.78 and currently yields dividends of 1.9%.

On 2025-11-05, Abbott(ABT) stock moved within a range of $123.92 to $126.71. With shares now at $124.54, the stock is trading +0.5% above its intraday low and -1.7% below the session's peak.

Trading volume for Abbott(ABT) stock has reached 4.56M, versus its average volume of 5.75M.

The stock's 52-week range extends from a low of $110.86 to a high of $141.23.

The stock's 52-week range extends from a low of $110.86 to a high of $141.23.

ABT News

Simply Wall St 13h
Abbott Laboratories' Earnings Are Weaker Than They Seem

Abbott Laboratories ( ) announced strong profits, but the stock was stagnant. Our analysis suggests that shareholders have noticed something concerning in the n...

Abbott Laboratories' Earnings Are Weaker Than They Seem
Nasdaq 5d
Peter Lynch Detailed Fundamental Analysis - ABT

Below is Validea's guru fundamental report for ABBOTT LABORATORIES (ABT). Of the 22 guru strategies we follow, ABT rates highest using our P/E/Growth Investor m...

Peter Lynch Detailed Fundamental Analysis - ABT

Analyst ratings

64%

of 33 ratings
Buy
63.6%
Hold
36.4%
Sell
0%

People also own

Based on the portfolios of people who own ABT. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.